Free Trial

Rhythm Pharmaceuticals (RYTM) News Today

Rhythm Pharmaceuticals logo
$65.66 -0.01 (-0.02%)
As of 12:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

RYTM Latest News

Rhythm Pharmaceuticals, Inc. stock logo
Hennion & Walsh Asset Management Inc. Has $4.75 Million Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Hennion & Walsh Asset Management Inc. cut its stake in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 9.9% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 89,622 shares of the company's stock after selling 9,825
Rhythm Pharmaceuticals, Inc. stock logo
76,084 Shares in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Bought by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 76,084 shares of the com
Rhythm Pharmaceuticals, Inc. stock logo
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Holdings Cut by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 3.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional inv
Rhythm Pharmaceuticals, Inc. stock logo
Stifel Nicolaus Raises Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $94.00
Stifel Nicolaus boosted their price objective on Rhythm Pharmaceuticals from $78.00 to $94.00 and gave the company a "buy" rating in a research note on Thursday.
Rhythm Pharmaceuticals, Inc. stock logo
Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading Up 4.7% - Here's Why
Rhythm Pharmaceuticals (NASDAQ:RYTM) Shares Up 4.7% - Time to Buy?
Rhythm Pharmaceuticals, Inc. stock logo
Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading Down 4.1% - Should You Sell?
Rhythm Pharmaceuticals (NASDAQ:RYTM) Shares Down 4.1% - Should You Sell?
Rhythm Pharmaceuticals, Inc. stock logo
Ameriprise Financial Inc. Purchases 11,480 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Ameriprise Financial Inc. raised its stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 27.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,367 shares of the company's stock after
Rhythm Pharmaceuticals, Inc. stock logo
Voloridge Investment Management LLC Purchases 27,214 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Voloridge Investment Management LLC boosted its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 7.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 380,537 shares of the company's stock af
Rhythm Pharmaceuticals, Inc. stock logo
ProShare Advisors LLC Grows Stock Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
ProShare Advisors LLC increased its stake in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 31.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 18,328 shares of
Rhythm Pharmaceuticals, Inc. stock logo
Deutsche Bank AG Has $2.73 Million Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Deutsche Bank AG increased its position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 46.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 48,745 shares of the company's stock after purchasing an additional 15,481 shar
Rhythm Pharmaceuticals, Inc. stock logo
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Position Trimmed by Frazier Life Sciences Management L.P.
Frazier Life Sciences Management L.P. lessened its stake in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 22.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,869,808 shares of the comp
Rhythm Pharmaceuticals, Inc. stock logo
Rafferty Asset Management LLC Sells 14,182 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Rafferty Asset Management LLC cut its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 22.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 50,394 shares of the company'
Rhythm Pharmaceuticals, Inc. stock logo
D. E. Shaw & Co. Inc. Buys 43,904 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
D. E. Shaw & Co. Inc. increased its stake in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 1,022.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 48,198 shares of the company's stock after purchasing an additional 43,
Rhythm Pharmaceuticals, Inc. stock logo
OMERS ADMINISTRATION Corp Takes $425,000 Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
OMERS ADMINISTRATION Corp purchased a new position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 7,600 shares of the company's stock, valued at approximately $425,000. Other ins
Rhythm Pharmaceuticals, Inc. stock logo
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Average Rating of "Buy" from Analysts
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) has earned a consensus rating of "Buy" from the thirteen brokerages that are presently covering the firm, MarketBeat Ratings reports. Thirteen research analysts have rated the stock with a buy recommendation. The average 1-year target pr
Rhythm Pharmaceuticals, Inc. stock logo
Lazard Asset Management LLC Acquires New Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Lazard Asset Management LLC acquired a new stake in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 106,261 shares of the company's stock, valued at approximate
Rhythm Pharmaceuticals, Inc. stock logo
Janus Henderson Group PLC Acquires 621,432 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Janus Henderson Group PLC boosted its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 103.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,219,554 shares of the comp
Rhythm Pharmaceuticals, Inc. stock logo
BNP Paribas Financial Markets Purchases 70,824 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
BNP Paribas Financial Markets raised its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 491.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 85,249 shares of the comp
Rhythm Pharmaceuticals, Inc. stock logo
Orbimed Advisors LLC Reduces Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Orbimed Advisors LLC decreased its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 8.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 400,000 shares of the company's stoc
Rhythm FY Net Y758.00M Vs Net Y477.00M
Rhythm Pharmaceuticals, Inc. stock logo
Integral Health Asset Management LLC Invests $8.40 Million in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Integral Health Asset Management LLC purchased a new position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 150,000 shares of the company's stock, valu
Rhythm Pharmaceuticals, Inc. stock logo
Northern Trust Corp Has $30.53 Million Stock Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Northern Trust Corp grew its holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 9.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 545,314 shares of the company's stock after purchasing an additi
Rhythm Pharmaceuticals, Inc. stock logo
HC Wainwright Has Negative Estimate for RYTM Q2 Earnings
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) - Research analysts at HC Wainwright decreased their Q2 2025 earnings estimates for Rhythm Pharmaceuticals in a research note issued on Thursday, May 8th. HC Wainwright analyst R. Selvaraju now forecasts that the company will earn ($0.76) p
Rhythm Pharmaceuticals, Inc. stock logo
138,363 Shares in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Acquired by Balyasny Asset Management L.P.
Balyasny Asset Management L.P. acquired a new stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 138,363 shares of the company's stock, val
Rhythm Pharmaceuticals, Inc. stock logo
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Purchased by The Manufacturers Life Insurance Company
The Manufacturers Life Insurance Company increased its holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 23.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 59,969 shares of the company's stock after purc
Rhythm Pharmaceuticals, Inc. stock logo
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Acquired by Crestline Management LP
Crestline Management LP lifted its stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 31.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 25,062 shares of the company's stock after purchasing an additional 6,0
Rhythm Pharmaceuticals, Inc. stock logo
Algert Global LLC Reduces Stock Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Algert Global LLC lessened its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 23.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 41,551 shares of the company's stock
Rhythm Pharmaceuticals, Inc. stock logo
Driehaus Capital Management LLC Sells 8,515 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Driehaus Capital Management LLC cut its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 0.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,290,975
Rhythm Pharmaceuticals, Inc. stock logo
Bridgefront Capital LLC Makes New Investment in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Bridgefront Capital LLC acquired a new stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 4,604 shares of the company's stock, valued at approximately $258,000. A number of
Rhythm Pharmaceuticals, Inc. stock logo
Tudor Investment Corp ET AL Invests $853,000 in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Tudor Investment Corp ET AL bought a new position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 15,245 shares of the company's stock, valued at approximat
Rhythm Pharmaceuticals, Inc. stock logo
Mariner LLC Invests $254,000 in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Mariner LLC acquired a new position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 4,525 shares of the company's stock, valued at approximately
Rhythm Pharmaceuticals, Inc. stock logo
Hsbc Holdings PLC Invests $921,000 in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Hsbc Holdings PLC purchased a new stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 16,287 shares of the company's stock, valued at approximately $921,000. Several
Rhythm Pharmaceuticals, Inc. stock logo
Baker BROS. Advisors LP Sells 314,117 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Baker BROS. Advisors LP lessened its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 4.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 6,084,249 shares of the company's stock after selling 314,117 shares during the period. Rh
Rhythm Pharmaceuticals, Inc. stock logo
Bellevue Group AG Purchases 7,896 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Bellevue Group AG boosted its position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 50.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 23,596 shares of the company's stock after acquiring an add
Rhythm Pharmaceuticals, Inc. stock logo
Schonfeld Strategic Advisors LLC Acquires 29,165 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Schonfeld Strategic Advisors LLC grew its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 95.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 59,700 shares of the company's stock after buying an a
Rhythm Pharmaceuticals, Inc. stock logo
Tower Research Capital LLC TRC Acquires 4,161 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Tower Research Capital LLC TRC increased its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 1,100.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,539 shares of the company's stock after
Rhythm Pharmaceuticals, Inc. stock logo
Aquatic Capital Management LLC Makes New Investment in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Aquatic Capital Management LLC acquired a new stake in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 9,223 shares of the company's stock,
Rhythm Pharmaceuticals, Inc. stock logo
Voya Investment Management LLC Sells 5,663 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Voya Investment Management LLC reduced its stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 5.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 97,169 shares of the company's
Rhythm Pharmaceuticals, Inc. stock logo
PDT Partners LLC Acquires 32,083 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
PDT Partners LLC boosted its stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 279.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 43,583 shares of the company's stock after acquiring an add
Rhythm Pharmaceuticals, Inc. stock logo
Rhythm Pharmaceuticals (RYTM) Projected to Post Earnings on Wednesday
Rhythm Pharmaceuticals (NASDAQ:RYTM) will be releasing its Q1 2025 earnings before the market opens on Wednesday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-7-rhythm-pharmaceuticals-inc-stock/)
Get Rhythm Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RYTM and its competitors with MarketBeat's FREE daily newsletter.

RYTM Media Mentions By Week

RYTM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RYTM
News Sentiment

0.99

0.86

Average
Medical
News Sentiment

RYTM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RYTM Articles
This Week

11

7

RYTM Articles
Average Week

Get Rhythm Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RYTM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:RYTM) was last updated on 6/4/2025 by MarketBeat.com Staff
From Our Partners